What is LeoMed?
LeoMed operates as a sophisticated, customizable health monitoring platform designed to empower care teams, researchers, and administrators. By providing a no-code care journey creator and seamless integration with hundreds of biometric devices, the company enables healthcare institutions to design personalized patient engagement pathways. Unlike rigid legacy systems, LeoMed offers a flexible architecture that allows providers to tailor their monitoring protocols to specific clinical needs. With over two decades of collective expertise in telehealth, IT, and cybersecurity, the company is uniquely equipped to address the rigorous demands of modern healthcare environments, ensuring that institutions can meet their monitoring objectives without compromising on security or operational efficiency.
How much funding has LeoMed raised?
LeoMed has raised a total of $2.8M across 1 funding round:
Seed
$2.8M
Seed (2025): $2.8M with participation from Precicom Technologies
Key Investors in LeoMed
Precicom Technologies
Precicom Technologies is a specialized provider of cybersecurity, IT governance, and managed IT services, focusing on digital resilience for public and private sector organizations.
What's next for LeoMed?
Following this major strategic investment, LeoMed is poised to transition from its current development phase into a period of aggressive scaling. The capital will likely be deployed to enhance the platform's interoperability, expand its library of connected biometric devices, and strengthen its cybersecurity framework to meet the evolving needs of large-scale healthcare providers. As the industry shifts toward decentralized care models, LeoMed's focus on customizable, patient-centric workflows positions it as a critical player in the digital health ecosystem. Future growth will likely center on deepening partnerships with clinical institutions and refining its AI-driven analytics to further improve patient outcomes and operational productivity.
See full LeoMed company page
